Curis, Inc. to Showcase Innovations at Healthcare Conferences in September 2025
Curis, Inc., a biotechnology company dedicated to pioneering drug development, has announced its participation in several significant healthcare conferences this September. With a focus on their drug emavusertib (CA-4948), a promising orally available IRAK4 inhibitor, Curis aims to showcase its advancements in clinical research and drug approval processes.
CEO James Dentzer will represent Curis at two prominent events:
1. Cantor Global Healthcare Conference 2025
- Dates: September 3 – 5, 2025
- Presentation Format: Fireside Chat
- Date of Presentation: September 5, 2025
- Time: 9:45 AM ET
- The presentation will be available via a webcast on Cantor.
CEO James Dentzer will represent Curis at two prominent events:
1. Cantor Global Healthcare Conference 2025
- Dates: September 3 – 5, 2025
- Presentation Format: Fireside Chat
- Date of Presentation: September 5, 2025
- Time: 9:45 AM ET
- The presentation will be available via a webcast on Cantor.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.